Irras AB
STO:IRRAS

Watchlist Manager
Irras AB Logo
Irras AB
STO:IRRAS
Watchlist
Price: 0.1604 SEK -1.11% Market Closed
Market Cap: kr181.7m

Operating Margin

-460.1%
Current
Declining
by 15.6%
vs 3-y average of -444.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-460.1%
=
Operating Income
kr-198.3m
/
Revenue
kr43.1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-460.1%
=
Operating Income
kr-198.3m
/
Revenue
kr43.1m

Peer Comparison

Country Company Market Cap Operating
Margin
SE
Irras AB
STO:IRRAS
181.7m SEK
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.2B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
186.4B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
138.2B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
130.1B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.9B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.4B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.1B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.7B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.4B USD
Loading...

Market Distribution

Lower than 91% of companies in Sweden
Percentile
9th
Based on 2 047 companies
9th percentile
-460.1%
Low
-2 025 693.8% — -1.8%
Typical Range
-1.8% — 12.5%
High
12.5% — 10 459.2%
Distribution Statistics
Sweden
Min -2 025 693.8%
30th Percentile -1.8%
Median 6%
70th Percentile 12.5%
Max 10 459.2%

Irras AB
Glance View

Market Cap
181.7m SEK
Industry
Health Care

Irras AB engages in the development, design, and commercialization of solutions for the treatment of brain pathologies. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2017-11-22. The company offers devices for fluid control and management for a broad range of brain pathologies, central nervous system (CNS) therapeutic applications and procedures. The offer comprises instruments and catheters for the clinical, monitoring and surgical applications for brain pathology indications called IRRAflow. The IRRAflow CNS System combines an External Drainage System, an intracranial pressure monitoring (ICP) Monitor and an Occlusion Solution Mechanism into a single, integrated device. The primary market for IRRAflow is the United States. The Company’s shareholders comprise Vandel Medical Equipment (CY) Limited, Serendipity Ixora AB (publ) and F.EX Endotherapy Limited, among others.

IRRAS Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-460.1%
=
Operating Income
kr-198.3m
/
Revenue
kr43.1m
What is Irras AB's current Operating Margin?

The current Operating Margin for Irras AB is -460.1%, which is below its 3-year median of -444.5%.

How has Operating Margin changed over time?

Over the last 3 years, Irras AB’s Operating Margin has increased from -1 976% to -460.1%. During this period, it reached a low of -1 976% on May 30, 2020 and a high of -417.8% on Dec 31, 2022.

Back to Top